Iron Deficiency and Anemia, Inflammatory Bowel Disease (IBD) — Assessment of Response to Iron Therapy — Clinical Pathway: Outpatient Specialty Care and Primary Care

Inflammatory Bowel Disease with Iron Deficiency and Anemia Clinical Pathway — All Settings

Assessment of Response to Iron Therapy

Assess response in anemic patients in 4 weeks
Normalization or increase in Hb by ≥ 2g/dL from baseline
No response to treatment
Patient receiving oral iron
Patient receiving IV iron
Evaluate tolerance,
compliance
Consider use of IV iron
  • Reassess
    • Disease activity
    • Blood loss
  • Assess
    • Other causes of anemia
  • Consider
    • Hematology referral